Product Name | MF | CAS | Details |
---|
Sitagliptin-d4 phosphate | C16H18F6N5O5P | 1432063-88-1 | Details |
TOR1B antibody | Details |
3-(3,4-Dichlorophenyl)propan-1-ol | C9H10Cl2O | 39960-05-9 | Details |
Methyl bromoacetate | C3H5BrO2 | 96-32-2 | Details |
BNP-32, porcine | C149H250N52O44S3 | 117345-87-6 | Details |
4-Nitro-1-(2,2,2-trifluoroethyl)-1H-pyrazole | C5H4F3N3O2 | 919278-38-9 | Details |
ZRANB2 antibody | Details |
2-(4-Nonylphenoxy)acetic acid | C17H26O3 | 3115-49-9 | Details |
[1-(But-3-yn-1-yl)-3-methylpiperidin-3-yl]methanol | 2154180-61-5 | Details |
rac-(3R,4S)-4-Phenylpyrrolidin-3-ol, trans | C10H13NO | 1242166-68-2 | Details |
3-(Trifluoromethyl)pyrazine-2-carbaldehyde | C6H3F3N2O | 1197238-20-2 | Details |
5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | C19H18ClN3O5S | 865479-71-6 | Details |
4-Chloro-1-(2,2-difluoroethyl)-1H-pyrazole-3-carboxylic acid | C6H5ClF2N2O2 | 1006486-42-5 | Details |
(E)-Coniferol | C10H12O3 | 32811-40-8 | Details |
2-tert-Butyl 3-methyl 8-imino-8-oxo-8λ6-thia-2-azaspiro[4.5]decane-2,3-dicarboxylate | 2361645-12-5 | Details |
β-Glucanase 2, thermostable | 62213-14-3 | Details |
SLC35E2 antibody | Details |
2-Nitrophenyl-beta-D-glucopyranoside | C12H15NO8 | 2816-24-2 | Details |
Rhod-FRHDSGY-OH | Details |
Mecamylamine HCL | C11H22ClN | 826-39-1 | Details |
1-[(1,5-Dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-amine | C10H18N4O2S | 1018996-02-5 | Details |
Dimethicone - 90% | C6H18OSi2 | 9006-65-9 | Details |
(S)-(-)-3-Chloro-1-phenyl-1-propanol | C9H11ClO | 100306-34-1 | Details |
5-Iodo-2-nitrobenzoic acid | C7H4INO4 | 35674-28-3 | Details |
cis-4-Hydroxy-L-proline | C5H9NO3 | 618-27-9 | Details |
N-Isopropylcycloheptanamine | C10H21N | 52703-18-1 | Details |
3-Methyl-4-(3-methylpyrrolidin-1-yl)benzonitrile | C13H16N2 | 1247450-79-8 | Details |
N-(4-(((4-methylpyrimidin-2-yl)amino)sulfonyl)phenyl)(4-(trifluoromethyl)phenyl)formamide | C19H15F3N4O3S | 667887-29-8 | Details |
O-tert-Butyl-L-threonine tert-butyl ester | C12H25NO3 | 5854-78-4 | Details |
(2-Phenylcyclopentyl)methanamine | C12H17N | 1504990-93-5 | Details |
GBM ELISA kit | Details |
CUGBP2 antibody | Details |
5-[(2-Methoxyphenyl)(methyl)sulfamoyl]-2-methylbenzoic acid | C16H17NO5S | 380342-16-5 | Details |
4-Fluoro-3-(methanesulfonyl)phenylboronic acid | C7H8BFO4S | 1268496-35-0 | Details |
LETM1 Blocking Peptide | Details |
Ethyl 2-cyano-4,4-dimethoxybutanoate | C9H15NO4 | 773076-83-8 | Details |
(3-Ethylazetidin-3-yl)methanol hydrochloride | C6H14ClNO | 1909310-02-6 | Details |
6-Fluorobenzofuran-3-carboxylic acid | C9H5FO3 | 1393561-25-5 | Details |
1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)ethan-1-one | C13H14N2O | 1210-43-1 | Details |
SSR 504734 hydrochloride | C20H20ClF3N2O.HCl | 615571-23-8 | Details |
Rabdosiin | C36H30O16 | 263397-69-9 | Details |
4-(1,1,2-trimethyl-1h-benzo[e]indolium-3-yl)butane-1-sulfonate | C19H23NO3S | 63149-24-6 | Details |
N-(2-methoxy-5-methylphenyl)-2-(4-(2-pyridyl)piperazinyl)ethanamide | C19H24N4O2 | 303091-92-1 | Details |
Ethyl[3-(pyrrolidin-1-yl)propyl]amine | C9H20N2 | 100708-28-9 | Details |
5-Methyl-L-norleucine | C7H15NO2 | 31872-98-7 | Details |
H-KSIHIGPGRAFYATG-OH | Details |
H-DYKDDDDKDYKDDDDKDYKDDDDK-OH | Details |
1-Phenyl-4-(propan-2-yl)-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one | C14H14N4O | 1105196-52-8 | Details |
1-(1H-Indol-5-yl)-2-methoxyethan-1-amine | 1270451-31-4 | Details |
L-Homoserine | C4H9NO3 | 672-15-1 | Details |
2,5-Dimethyl-1-propyl-1H-pyrrole | C9H15N | 20282-39-7 | Details |
HMGCR Antibody Positive Human Plasma | Details |
(His(3-Me)2)-TRH trifluoroacetate salt | C17H24N6O4 | 34367-54-9 | Details |
(2-Cyclopropylethyl)(cyclopropylmethyl)amine hydrochloride | C9H18ClN | 1989672-86-7 | Details |
7-Chloro-8-methylquinoline-3-carboxylic acid | C11H8ClNO2 | 948290-52-6 | Details |
2-[(4-Fluoro-2-methylphenyl)amino]acetonitrile | C9H9FN2 | 1021233-24-8 | Details |
Methyl 4-chloro-1H-pyrrole-2-carboxylate | C6H6ClNO2 | 1194-96-3 | Details |
2-Azido-2-deoxy-3,4-O-isopropylidene-6-O-toluenesulfonyl-L-idonic acid methyl ester | Details |
8,8'-Bibaicalein | C30H18O10 | 135309-02-3 | Details |
3-Amino-4-sulfanylbenzonitrile | C7H6N2S | 802559-53-1 | Details |
EG 00229 | C17H19N7O5S3 | 1018927-63-3 | Details |
1,2,3,4-Tetrahydro-1,8-naphthyridin-4-ol | C8H10N2O | 1379218-50-4 | Details |
(1-Cyanocycloheptyl)-carbamic acid tert-butyl ester | C13H22N2O2 | 904817-73-8 | Details |
1-(2-Methoxyethyl)-1-methylguanidine hydrochloride | C5H14ClN3O | 1423027-04-6 | Details |
2-(Methylsulfanyl)thiophene-3-carboxylic acid | C6H6O2S2 | 71154-30-8 | Details |
3,9-Dibromo-5H,6H,8H,9H-[1,2,4]triazolo[4,3-d][1,4]oxazepine | C6H7Br2N3O | 2060053-25-8 | Details |
1-[(5E)-5,6-Dideoxy-6-(diethoxy phosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil | C15H23N2O8P | 2095417-05-1 | Details |
H-VVLSQGSK-OH | Details |
4-Methyl-N-[2-(propan-2-yl)phenyl]piperazine-1-carbothioamide | C15H23N3S | 1154914-67-6 | Details |
3-Amino-4-(4-methyl-1H-pyrazol-1-yl)benzamide | C11H12N4O | 1182766-09-1 | Details |
Raucaffricine | C27H32N2O8 | 31282-07-2 | Details |
6-Cyano-1,2-dihydro-2-oxo-3-pyridinecarboxylic acid | C7H4N2O3 | 81450-71-7 | Details |
(1-Cyclopropylcyclopropyl)methanamine hydrochloride | C7H14ClN | 1423027-90-0 | Details |
4-Chloro-2-(2,6-dimethylpiperidine-1-carbonyl)aniline | C14H19ClN2O | 953745-28-3 | Details |
2-(3,4-Dimethylcyclohex-3-en-1-yl)propan-2-ol | C11H20O | 115941-97-4 | Details |
HLI 373 dihydrochloride | C18H24ClN5O2 | 1782531-99-0 | Details |
UGT1A9 Blocking Peptide | Details |
H-Pro-Arg-bNA·HCl | C21H29ClN6O2 | 201998-83-6 | Details |
NCoA2 antibody | Details |
TCTA Blocking Peptide | Details |
1,2-Diiodoethene | C2H2I2 | 590-27-2 | Details |
Haptoglobin (Mixed Phenotypes), Highly Purified | Details |
2-Aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride | 2253632-91-4 | Details |
4-[(tert-Butylamino)methyl]phenol hydrochloride | C11H18ClNO | 1197950-06-3 | Details |
5-Bromo-N,N,4-trimethylpyrimidin-2-amine | C7H10BrN3 | 1368039-53-5 | Details |
N-(3-Amino-2-methylphenyl)butanamide | C11H16N2O | 946725-64-0 | Details |
Protein Kinase C Substrate, Glycogen Synthase (1-8) | C56H104N18O15 | Details |
Methyl (3S)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride | C11H14ClNO3 | 178205-92-0 | Details |
N-(4-Amino-2-chlorophenyl)-5-ethylthiophene-2-carboxamide | C13H13ClN2OS | 1282572-28-4 | Details |
4-(1-Methyl-1H-imidazol-2-yl)piperidine | C9H15N3 | 1084976-68-0 | Details |
2-Bromo-2-cyclohexen-1-ol | C6H9BrO | 61426-49-1 | Details |
Atriopeptin I (rat) | C83H135N29O30S2 | 89139-53-7 | Details |
H-GDKA-OH | Details |
3-(Dimethylamino)-2,2-difluoropropan-1-ol hydrochloride | C5H12ClF2NO | 2305252-90-6 | Details |
1-(4-methoxyphenyl)-4-(4-nitrophenyl)imidazole-2-thiol | C16H13N3O3S | 97814-14-7 | Details |
Methyl 4-amino-2-methyl-1H-indole-1-carboxylate | C11H12N2O2 | 2219376-54-0 | Details |
rac-(1R,2R)-1-Bromo-2-methoxycyclohexane | C7H13BrO | 5927-93-5 | Details |
2'-Deoxy-5'-O-DMT-N2-isobutyrylguanosine 3'-Rp-oxazaphospholidine | Details |
Quinolin-4-amine hydrochloride | C9H9ClN2 | 35654-61-6 | Details |
Recombinant Mouse Fas Ligand | Details |
Product Total: Product Page: | ||||
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 |